ICB 特别专题:2023 年的亮点。

IF 3.2 4区 医学 Q3 CELL BIOLOGY
Joanne H Reed
{"title":"ICB 特别专题:2023 年的亮点。","authors":"Joanne H Reed","doi":"10.1111/imcb.12792","DOIUrl":null,"url":null,"abstract":"<p>In this Special Feature, we bring you the “Highlights of 2023”, a collection of short articles that discuss key research findings published in 2023 that advanced a specific research area of immunology. Booty<span><sup>1</sup></span> discusses recent mechanistic insights in T-cell immunometabolism, highlighting pathways and metabolites that modulate T effector and T regulatory (Treg) cell function in cancer and autoimmunity. Zhang and Chong<span><sup>2</sup></span> review key findings demonstrating the roles of microRNA in T-cell apoptosis and differentiation and Treg proliferation in experimental autoimmune encephalomyelitis and myeloma. Makuyana and Liston<span><sup>3</sup></span> focus on publications revealing new functions for Treg cells in the lung, including in alveolar regeneration. Guo <i>et al</i>.<span><sup>4</sup></span> highlight work that has advanced our understanding of age-related effects on T cells with large-scale analyses showing genetic, transcriptomic and T-cell receptor repertoire changes with age. Pasquin<span><sup>5</sup></span> discusses key findings in the functional characterization and diversity of γδ T cells and mucosal-associated invariant T (MAIT) cells. Cellular therapy was a pivotal theme in 2023. Chinni <i>et al</i>.<span><sup>6</sup></span> highlight findings demonstrating how CD4<sup>+</sup> T cells impact the manufacturing and quality of chimeric antigen receptor (CAR) T-cell products and contribute to long-term tumor control and adverse events such as cytokine release syndrome. Lee and Reed<span><sup>7</sup></span> discuss current clinical trials and basic research studies that are improving the specificity, safety and accessibility of CAR T-cell therapy for autoimmune disease. Bourel and Lesage<span><sup>8</sup></span> focus on publications defining the phenotypic, genetic and functional attributes that influence natural killer (NK) cell–mediated killing of tumor cells for the development of NK cellular therapies. Lam and Souza-Fonseca-Guimaraes<span><sup>9</sup></span> continue the NK cell theme, highlighting technological advances in genomics and proteomics that elucidate key functions of NK cells in cancer and infection. Lombard-Vadnais and Lesage<span><sup>10</sup></span> uncover the role of class switching in thymic B cells for negative selection of CD4<sup>+</sup> thymocytes and Treg generation. Barra and Marshall<span><sup>11</sup></span> highlight key findings on the diversity and function of mast cells and how they integrate with host defense to prevent immune-mediated damage in barrier tissues and the central nervous system. Dashwood and Liston<span><sup>12</sup></span> bring us up to date on microglia biology, with mechanistic insights into cognitive development, synaptic pruning and new approaches to evaluate microglia function. Van Nieuwenhove<span><sup>13</sup></span> highlights major translational advances in the detection and treatment of monogenic and polygenic pediatric immune deficiencies, autoimmunity and autoinflammation. Pankhurst and Linterman<span><sup>14</sup></span> summarize many key discoveries in the germinal center field and the implications for long-lived humoral immunity. Together, this collection of Research Highlights is designed to update and celebrate key discoveries in immunology in 2023.</p><p>The author declares no conflicts of interest.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"102 6","pages":"412-413"},"PeriodicalIF":3.2000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12792","citationCount":"0","resultStr":"{\"title\":\"ICB Special Feature: Highlights of 2023\",\"authors\":\"Joanne H Reed\",\"doi\":\"10.1111/imcb.12792\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In this Special Feature, we bring you the “Highlights of 2023”, a collection of short articles that discuss key research findings published in 2023 that advanced a specific research area of immunology. Booty<span><sup>1</sup></span> discusses recent mechanistic insights in T-cell immunometabolism, highlighting pathways and metabolites that modulate T effector and T regulatory (Treg) cell function in cancer and autoimmunity. Zhang and Chong<span><sup>2</sup></span> review key findings demonstrating the roles of microRNA in T-cell apoptosis and differentiation and Treg proliferation in experimental autoimmune encephalomyelitis and myeloma. Makuyana and Liston<span><sup>3</sup></span> focus on publications revealing new functions for Treg cells in the lung, including in alveolar regeneration. Guo <i>et al</i>.<span><sup>4</sup></span> highlight work that has advanced our understanding of age-related effects on T cells with large-scale analyses showing genetic, transcriptomic and T-cell receptor repertoire changes with age. Pasquin<span><sup>5</sup></span> discusses key findings in the functional characterization and diversity of γδ T cells and mucosal-associated invariant T (MAIT) cells. Cellular therapy was a pivotal theme in 2023. Chinni <i>et al</i>.<span><sup>6</sup></span> highlight findings demonstrating how CD4<sup>+</sup> T cells impact the manufacturing and quality of chimeric antigen receptor (CAR) T-cell products and contribute to long-term tumor control and adverse events such as cytokine release syndrome. Lee and Reed<span><sup>7</sup></span> discuss current clinical trials and basic research studies that are improving the specificity, safety and accessibility of CAR T-cell therapy for autoimmune disease. Bourel and Lesage<span><sup>8</sup></span> focus on publications defining the phenotypic, genetic and functional attributes that influence natural killer (NK) cell–mediated killing of tumor cells for the development of NK cellular therapies. Lam and Souza-Fonseca-Guimaraes<span><sup>9</sup></span> continue the NK cell theme, highlighting technological advances in genomics and proteomics that elucidate key functions of NK cells in cancer and infection. Lombard-Vadnais and Lesage<span><sup>10</sup></span> uncover the role of class switching in thymic B cells for negative selection of CD4<sup>+</sup> thymocytes and Treg generation. Barra and Marshall<span><sup>11</sup></span> highlight key findings on the diversity and function of mast cells and how they integrate with host defense to prevent immune-mediated damage in barrier tissues and the central nervous system. Dashwood and Liston<span><sup>12</sup></span> bring us up to date on microglia biology, with mechanistic insights into cognitive development, synaptic pruning and new approaches to evaluate microglia function. Van Nieuwenhove<span><sup>13</sup></span> highlights major translational advances in the detection and treatment of monogenic and polygenic pediatric immune deficiencies, autoimmunity and autoinflammation. Pankhurst and Linterman<span><sup>14</sup></span> summarize many key discoveries in the germinal center field and the implications for long-lived humoral immunity. Together, this collection of Research Highlights is designed to update and celebrate key discoveries in immunology in 2023.</p><p>The author declares no conflicts of interest.</p>\",\"PeriodicalId\":179,\"journal\":{\"name\":\"Immunology & Cell Biology\",\"volume\":\"102 6\",\"pages\":\"412-413\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12792\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology & Cell Biology\",\"FirstCategoryId\":\"2\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12792\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12792","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在本特辑中,我们将为您带来 "2023 年亮点",这是一组讨论 2023 年发表的、推动免疫学特定研究领域发展的重要研究成果的短文集。Booty1讨论了T细胞免疫代谢的最新机理见解,重点介绍了在癌症和自身免疫中调节T效应细胞和T调节(Treg)细胞功能的途径和代谢产物。Zhang和Chong2回顾了在实验性自身免疫性脑脊髓炎和骨髓瘤中证明微RNA在T细胞凋亡和分化以及Treg增殖中作用的重要发现。Makuyana 和 Liston3 重点介绍了揭示 Treg 细胞在肺部(包括肺泡再生)新功能的论文。Guo 等人4 重点介绍了通过大规模分析显示基因、转录组和 T 细胞受体组随着年龄的增长而发生变化,从而加深了我们对年龄对 T 细胞影响的理解。Pasquin5 讨论了γδ T 细胞和粘膜相关不变 T 细胞(MAIT)的功能特征和多样性方面的重要发现。细胞疗法是2023年的一个重要主题。Chinni等人6重点介绍了CD4+ T细胞如何影响嵌合抗原受体(CAR)T细胞产品的生产和质量,以及如何促进长期肿瘤控制和细胞因子释放综合征等不良反应的研究结果。Lee 和 Reed7 讨论了当前的临床试验和基础研究,这些研究正在提高 CAR T 细胞疗法治疗自身免疫性疾病的特异性、安全性和可及性。Bourel 和 Lesage8 重点介绍了有关影响自然杀伤(NK)细胞介导的肿瘤细胞杀伤的表型、遗传和功能特性的出版物,以开发 NK 细胞疗法。Lam和Souza-Fonseca-Guimaraes9继续以NK细胞为主题,重点介绍了基因组学和蛋白质组学方面的技术进展,这些进展阐明了NK细胞在癌症和感染中的关键功能。Lombard-Vadnais和Lesage10揭示了胸腺B细胞在CD4+胸腺细胞负向选择和Treg生成中的类别转换作用。Barra 和 Marshall11 重点介绍了肥大细胞的多样性和功能,以及肥大细胞如何与宿主防御相结合,防止屏障组织和中枢神经系统中免疫介导的损伤。Dashwood 和 Liston12 为我们介绍了小胶质细胞生物学的最新进展,包括对认知发展、突触修剪和评估小胶质细胞功能的新方法的机理认识。Van Nieuwenhove13 重点介绍了在检测和治疗单基因和多基因小儿免疫缺陷、自身免疫和自身炎症方面取得的重大转化进展。Pankhurst 和 Linterman14 总结了生殖中心领域的许多重要发现以及对长效体液免疫的影响。本研究亮点集旨在更新和庆祝 2023 年免疫学领域的重要发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
ICB Special Feature: Highlights of 2023

In this Special Feature, we bring you the “Highlights of 2023”, a collection of short articles that discuss key research findings published in 2023 that advanced a specific research area of immunology. Booty1 discusses recent mechanistic insights in T-cell immunometabolism, highlighting pathways and metabolites that modulate T effector and T regulatory (Treg) cell function in cancer and autoimmunity. Zhang and Chong2 review key findings demonstrating the roles of microRNA in T-cell apoptosis and differentiation and Treg proliferation in experimental autoimmune encephalomyelitis and myeloma. Makuyana and Liston3 focus on publications revealing new functions for Treg cells in the lung, including in alveolar regeneration. Guo et al.4 highlight work that has advanced our understanding of age-related effects on T cells with large-scale analyses showing genetic, transcriptomic and T-cell receptor repertoire changes with age. Pasquin5 discusses key findings in the functional characterization and diversity of γδ T cells and mucosal-associated invariant T (MAIT) cells. Cellular therapy was a pivotal theme in 2023. Chinni et al.6 highlight findings demonstrating how CD4+ T cells impact the manufacturing and quality of chimeric antigen receptor (CAR) T-cell products and contribute to long-term tumor control and adverse events such as cytokine release syndrome. Lee and Reed7 discuss current clinical trials and basic research studies that are improving the specificity, safety and accessibility of CAR T-cell therapy for autoimmune disease. Bourel and Lesage8 focus on publications defining the phenotypic, genetic and functional attributes that influence natural killer (NK) cell–mediated killing of tumor cells for the development of NK cellular therapies. Lam and Souza-Fonseca-Guimaraes9 continue the NK cell theme, highlighting technological advances in genomics and proteomics that elucidate key functions of NK cells in cancer and infection. Lombard-Vadnais and Lesage10 uncover the role of class switching in thymic B cells for negative selection of CD4+ thymocytes and Treg generation. Barra and Marshall11 highlight key findings on the diversity and function of mast cells and how they integrate with host defense to prevent immune-mediated damage in barrier tissues and the central nervous system. Dashwood and Liston12 bring us up to date on microglia biology, with mechanistic insights into cognitive development, synaptic pruning and new approaches to evaluate microglia function. Van Nieuwenhove13 highlights major translational advances in the detection and treatment of monogenic and polygenic pediatric immune deficiencies, autoimmunity and autoinflammation. Pankhurst and Linterman14 summarize many key discoveries in the germinal center field and the implications for long-lived humoral immunity. Together, this collection of Research Highlights is designed to update and celebrate key discoveries in immunology in 2023.

The author declares no conflicts of interest.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Immunology & Cell Biology
Immunology & Cell Biology 医学-免疫学
CiteScore
7.50
自引率
2.50%
发文量
98
审稿时长
4-8 weeks
期刊介绍: The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信